vVARDIS Holding AG
VVVV
New listing · first traded Nov 13, 2026 on NYSE · source: SEC EDGAR
Below: live stock price for vVARDIS Holding AG (VVVV), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
vVARDIS Holding AG (VVVV) is a Healthcare company based in Switzerland. Operating in Medical Instruments & Supplies, it employs about 153 people. Over the past year VVVV traded between 14 and 16.95 USD.
- Prev close
- $15.00
- Volume (24h)
- $4.97M
- Market cap
- $770.91M
- Currency
- USD
Scoreas of Nov 21, 2026
38/ 100 · Weak
- Value—
- Quality50
- Momentum25
- Growth100
- Risk—
- Dividend0
- Liquidity14
Composite of public market data. Informational only — not investment advice.
Trend projection
Not enough history to project a trend.
Interpretation
The composite score is in the weak range. Strength: growth with weakness: dividend.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Quality50/100
Quality looks mixed — driven by Profit margin (-105.16%).
Profit margin:-105.16%Gross margin:85.39% - Momentum25/100
Momentum looks fragile — driven by 52w change (-11.82%).
52w change:-11.82% - Growth100/100
Growth looks strong — driven by Revenue growth (214.20%).
Revenue growth:214.20% - Dividend0/100
Dividend looks fragile — driven by Dividend yield (0.00%).
Dividend yield:0.00% - Liquidity14/100
Liquidity looks fragile — driven by Current ratio (0.96).
Current ratio:0.96Quick ratio:0.59
Derived from public market data — informational, not investment advice.
Pivot points
Daily, from the November 20 session's high, low and close
High 14.97 · Low 14.54 · Close 14.55
| Level | Classic | Fibonacci | Camarilla |
|---|---|---|---|
| R3 | 15.26 | 15.12 | 14.67 |
| R2 | 15.12 | 14.95 | 14.63 |
| R1 | 14.83 | 14.85 | 14.59 |
| Pivot | 14.69 | 14.69 | 14.69 |
| S1 | 14.40 | 14.52 | 14.51 |
| S2 | 14.26 | 14.42 | 14.47 |
| S3 | 13.97 | 14.26 | 14.43 |
Pivot points are reference levels computed with standard formulas from the previous session's range. They are not a forecast and not a buy or sell signal.
Weekly and monthly pivots, Woodie and DeMark: pivot point calculator →Historical data
Daily prices for the latest sessions, newest first
| Date | Close | Open | High | Low | Volume | Change % |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 14.55 | 14.89 | 14.97 | 14.54 | 4.97M | -3.00% |
| Nov 19, 2026 | 15.00 | 15.50 | 16.12 | 14.96 | 7.28M | -3.04% |
| Nov 18, 2026 | 15.47 | 15.75 | 15.88 | 15.40 | 5.14M | -2.09% |
| Nov 17, 2026 | 15.80 | 15.75 | 16.29 | 15.68 | 2.55M | -1.25% |
| Nov 16, 2026 | 16.00 | 16.07 | 16.95 | 15.95 | 10.82M | -3.03% |
Financials
- 52w high
- $16.95
- 52w low
- $14.00
- 52w change
- -11.82%
- Day high
- $14.97
- Day low
- $14.54
- Enterprise value
- 612.5M
- EV / Revenue
- 12.33
- EV / EBITDA
- -20.56
- EPS (TTM)
- -$0.29
- Dividend yield
- 0.00%
- Revenue (TTM)
- 49.68M
- EBITDA
- -29.79M
- Total cash
- 28.97M
- Total debt
- 86.37M
- Current ratio
- 0.96
- Quick ratio
- 0.59
- Profit margin
- -105.16%
- Gross margin
- 85.39%
- Shares outstanding
- 38.59M
- Float
- 2.96M
vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.
Analyst & Risk
Analysts' consensus via Yahoo Finance — not investment advice.
- 52-week change
- -11.82%
- Current ratio
- 0.96
- Quick ratio
- 0.59
- EV / Revenue
- 12.33
- EV / EBITDA
- -20.56
- Revenue growth
- 214.20%
- EBITDA
- -29.79M
- Total cash
- 28.97M
- Total debt
- 86.37M
- Insider holdings
- 146.04%
- Institutional
- 0.00%
Analyst estimates
Consensus of research analysts' forecasts, compiled by Yahoo Finance · as of Nov 21, 2026
| Period | EPS estimate | EPS vs a year earlier | Revenue estimate | Revenue vs a year earlier |
|---|---|---|---|---|
| Current quarter | — | — | 0range 0 – 00 analysts | — |
| Next quarter | — | — | 0range 0 – 00 analysts | — |
| Current fiscal year | — | — | 0range 0 – 00 analysts | — |
| Next fiscal year | — | — | 0range 0 – 00 analysts | — |
Financial documents
Recent news
- Has vVARDIS Holding (VVVV) Fallen Enough to Sit Below Fair Value?Simply Wall St.7 days ago
- vVARDIS Holding (VVVV) Debuts Below Its IPO Price, Is The Pullback Already Justified?Simply Wall St.7 days ago
- What Does vVARDIS Holding (VVVV) Listing Mean For Its Drill Free Dental Push?Simply Wall St.7 days ago
- The NYSE Welcomes vVARDIS as a Publicly Listed CompanyPR Newswire7 days ago
- The NYSE Welcomes vVARDIS as a Publicly Listed CompanyCNW Group7 days ago
- The NYSE Welcomes vVARDIS as a Publicly Listed CompanyPR Newswire7 days ago
- Weekly Gains Hold Up Despite a Friday Slide as Chips Lead and Yields ClimbCNW Group7 days ago
- vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content UpdatePR Newswire7 days ago
Related
Other assets in this category.
Live discussion
Sign in to join the discussion.